1. IQVIA. White paper: the impact of biosimilar competition in Europe 2022. Dec 2022. https://www.iqvia.com/library/white-papers/the-impact-of-biosimilar-competition-in-europe-2022. Accessed 30 Apr 2023.
2. Prasad V. Do cancer drugs improve survival or quality of life? BMJ. 2017;359: j4528. https://doi.org/10.1136/bmj.j4528.
3. The Center for Biosimilars. Scott Gottlieb, MD: phase 3 trials and biosimilars [Interview Transcript]. AJMC. 2019.
4. Blackstone EA, Joseph PF. The economics of biosimilars. Am Health Drug Benefits. 2013;6:469–78.
5. Federal Trade Commission. Emerging health care issues: Follow-on biologic drug competition. 2009. https://www.ftc.gov/sites/default/files/documents/reports/emerging-health-care-issues-follow-biologic-drug-competition-federal-trade-commission-report/p083901biologicsreport.pdf. Accessed 30 Apr 2023.